Analyst Ratings For Dynavax Technologies (NASDAQ:DVAX)
Today, Dynavax Technologies (NASDAQ:DVAX) stock was downgraded by JPMorgan Chase & Co. from Overweight to Neutral with a price target of $25.00.
Some recent analyst ratings include
- 2/14/2018-JPMorgan Chase & Co. was Downgraded by analysts at JPMorgan Chase & Co. from a “Overweight ” rating to a ” Neutral” rating. They now have a $25.00 price target on the stock, up previously from $31.00 .
- 11/3/2017-Cowen Reiterated Rating of Buy.
- 9/25/2017-Royal Bank of Canada Reiterated Rating of Outperform .
- 8/9/2017-William Blair Reiterated Rating of Outperform.
Recent Insider Trading Activity For Dynavax Technologies (NASDAQ:DVAX)
Dynavax Technologies (NASDAQ:DVAX) has insider ownership of 2.90% and institutional ownership of 68.60%.
- On 1/4/2018 David Louis Johnson, VP, sold 3,092 with an average share price of $18.60 per share and the total transaction amounting to $57,511.20.
- On 12/13/2017 Robert Coffman, Insider, sold 7,500 with an average share price of $18.90 per share and the total transaction amounting to $141,750.00.
- On 1/24/2017 Robert Janssen, VP, bought 6,000 with an average share price of $4.04 per share and the total transaction amounting to $24,240.00.
- On 6/28/2016 Robert Janssen, VP, bought 1,452 with an average share price of $13.68 per share and the total transaction amounting to $19,863.36.
- On 5/20/2016 Eddie Gray, CEO, bought 2,750 with an average share price of $15.57 per share and the total transaction amounting to $42,817.50.
- On 5/12/2016 Robert Janssen, VP, bought 1,000 with an average share price of $15.12 per share and the total transaction amounting to $15,120.00.
- On 8/14/2014 Eddie Gray, CEO, bought 25,000 with an average share price of $1.49 per share and the total transaction amounting to $37,250.00.
Recent Trading Activity for Dynavax Technologies (NASDAQ:DVAX)
Shares of Dynavax Technologies closed the previous trading session at 16.60 down -0.60 3.49% with shares trading hands.